Targeting Cancer Cell Death with Small Molecule Agents for Potential Therapeutics

Time has come to switch from morphological to molecular definitions of cell death subroutines, due to substantial progress in biochemical and genetic exploration. Currently, cell death subroutines are defined by a series of precise, measurable biochemical features; these include apoptosis, autophagic cell death and necroptosis. Accumulating evidence has gradually revealed the core molecular machinery of cell death in carcinogenesis; the intricate relationships between cell death subroutines and cancer, however, still need to be clarified. Cancer drug discovery, in particular, has benefitted significantly from a rapid progress in utilization of several small molecule compounds to target different cell death modularity. Thus, this review provides a comprehensive summary of the interrelationships between the cell death subroutines (e.g., apoptosis and autophagic cell death) and relevant anticancer small molecule compounds (e.g., Oridonin and Rapamycin). Moreover, these interconnections between different cell death subroutines may be integrated into the entire cell death network. This would be regarded as a potential cancer target for more small molecule drug discovery. Taken together, these findings may provide new and emerging clues that fill the gap between cell death subroutines and small molecule drugs for future cancer therapy.
Source: Springer protocols feed by Pharmacology/Toxicology - Category: Drugs & Pharmacology Source Type: news

Related Links:

CONCLUSIONS Our study reveals that RTHF-mediated inhibition of DUBs and proteasome may provide a potential strategy for cancer therapy. PMID: 30643111 [PubMed - in process]
Source: Medical Science Monitor - Category: Research Tags: Med Sci Monit Source Type: research
With advances in cancer therapy, diseases that were once fatal are becoming chronic disorders, often with adverse endocrine effects.Medscape Diabetes &Endocrinology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology Commentary Source Type: news
Cancer therapy decisions are often made according to the histopathological-molecular profile of tumor tissue obtained from surgery or biopsy. It has been shown that tumor profiles change with time and treatment, and that tumor tissue is heterogeneous. Thus, other approaches that are easily accessible and less invasive than surgery or biopsy to monitor responses to treatment and predict relapses are urgently needed. In the last few years, the term “liquid biopsies” has been introduced to represent multifunctional circulating biomarkers in the peripheral blood and other physiological fluids of patients with cance...
Source: Oncology - Category: Cancer & Oncology Source Type: research
Publication date: Available online 16 January 2019Source: Materials Science and Engineering: CAuthor(s): Catarina A. Reis, Carolina F. Rodrigues, André F. Moreira, Telma A. Jacinto, Paula Ferreira, Ilídio J. CorreiaAbstractCancer is one of the major world public health problems and the currently available treatments are nonspecific and ineffective. This reality highlights the importance of developing novel therapeutic approaches. In this field, multifunctional nanomedicines have the potential to revolutionize the currently available treatments. These unique nanodevices can simultaneously act as therapeutic an...
Source: Materials Science and Engineering: C - Category: Materials Science Source Type: research
(Natural News) It has been 16 years since the human genome was decoded — an accomplishment that scientists hoped would someday prove useful in cancer therapy. There was an optimistic, if not naive, belief that we could simply “switch off” cancer-causing genes. Nevertheless, oncologists are still encountering problems with this concept more than a decade...
Source: - Category: Consumer Health News Source Type: news
r Robert Lukowski Several tumor entities have been reported to overexpress KCa3.1 potassium channels due to epigenetic, transcriptional, or post-translational modifications. By modulating membrane potential, cell volume, or Ca2+ signaling, KCa3.1 has been proposed to exert pivotal oncogenic functions in tumorigenesis, malignant progression, metastasis, and therapy resistance. Moreover, KCa3.1 is expressed by tumor-promoting stroma cells such as fibroblasts and the tumor vasculature suggesting a role of KCa3.1 in the adaptation of the tumor microenvironment. Combined, this features KCa3.1 as a candidate target for inn...
Source: Cancers - Category: Cancer & Oncology Authors: Tags: Review Source Type: research
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.8b00836
Source: Molecular Pharmaceutics - Category: Drugs & Pharmacology Authors: Source Type: research
This study assessed gynecologists ’ and embryologists’ current practice, knowledge, and attitude concerning fertility preservation (FP) in cancer survivors. This current survey was performed on a convenience sample of 277 gynecologists and embryologists who attended large international congresses held across Iran. A 23-item self -administered questionnaire that included questions on knowledge, attitudes, and practice was used. Questions had either yes/no responses, or were answered based on a 4-point (1 to 4) Likert scored scale. Total mean score for knowledge of all FP options was 2.97 ± 0...
Source: Journal of Cancer Education - Category: Cancer & Oncology Source Type: research
Accumulated evidence has demonstrated that WNT1 inducible signaling pathway protein (WISP) genes, which belong to members of the CCN growth factor family, play a pivotal role in tumorigenesis and progression o...
Source: Journal of Translational Medicine - Category: Research Authors: Tags: Review Source Type: research
Authors: De Marinis F, Barberis M, Barbieri V, Marchianò A, Gasparini S, Migliorino MR, Romano G, Spinnato F, Vitiello F, Gridelli C Abstract INTRODUCTION: In the era of personalized cancer therapy, the sampling of adequate tumor tissue for histologic diagnosis and genomic profiling is crucial, not only at the initial diagnosis but also in the event of resistant and recurrent disease when sequential biopsies may be required to evaluate somatic mutations and histologic changes. Areas covered: The identification of genetic driver alterations led to the selection of patients who are most likely to benefit from ...
Source: Expert Review of Respiratory Medicine - Category: Respiratory Medicine Tags: Expert Rev Respir Med Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Therapy | Drugs & Pharmacology | Genetics | Toxicology